Terveystalo Oyj Past Earnings Performance
Past criteria checks 0/6
Terveystalo Oyj's earnings have been declining at an average annual rate of -36.1%, while the Healthcare industry saw earnings growing at 31.3% annually. Revenues have been growing at an average rate of 7.1% per year.
Key information
-36.1%
Earnings growth rate
-36.0%
EPS growth rate
| Healthcare Industry Growth | 12.6% |
| Revenue growth rate | 7.1% |
| Return on equity | -2.2% |
| Net Margin | -0.9% |
| Next Earnings Update | 14 Feb 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Terveystalo Oyj makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,329 | -11 | 12 | 0 |
| 30 Jun 24 | 1,313 | -23 | 11 | 0 |
| 31 Mar 24 | 1,296 | -30 | 9 | 0 |
| 31 Dec 23 | 1,286 | -42 | 9 | 0 |
| 30 Sep 23 | 1,279 | 30 | 10 | 0 |
| 30 Jun 23 | 1,275 | 7 | 12 | 0 |
| 31 Mar 23 | 1,271 | 10 | 11 | 0 |
| 31 Dec 22 | 1,259 | 24 | 9 | 0 |
| 30 Sep 22 | 1,252 | 43 | 12 | 0 |
| 30 Jun 22 | 1,249 | 77 | 14 | 0 |
| 31 Mar 22 | 1,206 | 82 | 11 | 0 |
| 31 Dec 21 | 1,155 | 81 | 7 | 0 |
| 30 Sep 21 | 1,107 | 77 | 11 | 0 |
| 30 Jun 21 | 1,074 | 79 | 4 | 0 |
| 31 Mar 21 | 1,008 | 61 | 4 | 0 |
| 31 Dec 20 | 986 | 46 | 5 | 0 |
| 30 Sep 20 | 977 | 40 | 8 | 0 |
| 30 Jun 20 | 971 | 34 | 8 | 0 |
| 31 Mar 20 | 1,020 | 46 | 8 | 0 |
| 31 Dec 19 | 1,031 | 54 | 7 | 0 |
| 30 Sep 19 | 958 | 48 | 19 | 0 |
| 30 Jun 19 | 885 | 54 | 26 | 0 |
| 31 Mar 19 | 815 | 59 | 34 | 0 |
| 31 Dec 18 | 745 | 69 | 41 | 0 |
| 30 Sep 18 | 737 | 65 | 45 | 0 |
| 30 Jun 18 | 732 | 42 | 45 | 0 |
| 31 Mar 18 | 727 | 29 | 53 | 0 |
| 31 Dec 17 | 690 | 7 | 42 | 0 |
| 30 Sep 17 | 646 | 9 | 38 | 0 |
| 30 Jun 17 | 610 | 16 | 35 | 0 |
| 31 Mar 17 | 567 | 16 | 22 | 0 |
| 31 Dec 16 | 547 | 13 | 30 | 0 |
| 31 Dec 15 | 506 | 1 | 31 | 0 |
| 31 Dec 14 | 474 | -83 | 30 | 0 |
Quality Earnings: 0RV1 is currently unprofitable.
Growing Profit Margin: 0RV1 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 0RV1 is unprofitable, and losses have increased over the past 5 years at a rate of 36.1% per year.
Accelerating Growth: Unable to compare 0RV1's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 0RV1 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (14.3%).
Return on Equity
High ROE: 0RV1 has a negative Return on Equity (-2.15%), as it is currently unprofitable.